David L. Lewis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David L. Lewis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David L. Lewis. David L. Lewis is Chief Scientific Officer in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).
Latest Insider Trading Transactions of David L. Lewis
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | A | 6.15 | 85,000 | 522,750 | 472,500 | |
Mar 10 2015 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | A | 7.75 | 100,000 | 775,000 | 387,500 | |
Jan 07 2015 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | M | 2.01 | 15,000 | 30,150 | 287,500 | |
Jan 07 2015 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Sell | S | 8.01 | 15,000 | 120,104 | 0 | 15 K to 0 (-100.00 %) |
Jan 07 2015 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 2.01 | 15,000 | 30,150 | 15,000 | 0 to 15 K |
Sep 30 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | M | 2.01 | 15,000 | 30,150 | 302,500 | |
Sep 30 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Sell | S | 15.02 | 15,000 | 225,350 | 0 | 15 K to 0 (-100.00 %) |
Sep 30 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 2.01 | 15,000 | 30,150 | 15,000 | 0 to 15 K |
Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | A | 14.54 | 120,000 | 1,744,800 | 317,500 | |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | M | 2.62 | 2,500 | 6,550 | 197,500 | |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | M | 5.19 | 2,500 | 12,975 | 200,000 | |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | M | 4.60 | 10,000 | 46,000 | 202,500 | |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Sell | S | 10.29 | 15,000 | 154,292 | 0 | 15 K to 0 (-100.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 2.62 | 2,500 | 6,550 | 15,000 | 12.5 K to 15 K (+20.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 5.19 | 2,500 | 12,975 | 12,500 | 10 K to 12.5 K (+25.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 4.60 | 10,000 | 46,000 | 10,000 | 0 to 10 K |
Page: 1